Cost Efficiency of Treatments for the Schizophrenic Patient
Abstract
The findings of a controlled experimental study in which five treatment methods were compared by both clinical and cost criteria indicate that, for most schizophrenic patient, milieu care alone is both expensive and relatively ineffective. In terms of cost per patient released and cost per case treated, it is far less expensive to provide the most effective available treatment than to merely provide a good level of milieu care without special additional treatment.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
